4D Molecular Therapeutics Inc

NASDAQ:FDMT

22.88

-0.38 (-1.63%)

2:40:32 PM EDT: $22.19 -0.69 (-3.02%)

Market Cap (Intraday)	729.06M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$3 Million
Adjusted EPS	-$0.80

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

4D Molecular Therapeutics Inc Stock, NASDAQ:FDMT

5858 Horton Street, Suite 455, Emeryville, California 94608

United States of America

Phone: +1.510.505.2680

Number of Employees: 124

http://www.4dmoleculartherapeutics.com

Description

4D Molecular Therapeutics, Inc. engages in the design, development, and commercialization of transformative gene therapeutic products for serious unmet medical conditions. It offers products for ophthalmology, cardiology, and pulmonology. The company was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.